LBF20207PG37: Difference between revisions
No edit summary |
No edit summary |
||
| Line 11: | Line 11: | ||
|Chemical Synthesis= | |Chemical Synthesis= | ||
|Metabolism= | |Metabolism= | ||
|Biological Activity= Prostaglandin | |Biological Activity= Prostaglandin F2 alpha 1,15-lactone terminates pregnancy at early stage.[[Reference:Spilman_CH:Beuving_DC:Forbes_AD:Kimball_FA:,Prostaglandins,1977,14,477|{{RelationTable/GetFirstAuthor|Reference:Spilman_CH:Beuving_DC:Forbes_AD:Kimball_FA:,Prostaglandins,1977,14,477}}]] | ||
}} | }} | ||
{{Lipid/Footer}} | {{Lipid/Footer}} | ||
Revision as of 14:00, 19 February 2010
| LipidBank Top (トップ) |
Fatty acid (脂肪酸) |
Glycerolipid (グリセロ脂質) |
Sphingolipid (スフィンゴ脂質) |
Journals (雑誌一覧) |
How to edit (ページの書き方) |
| IDs and Links | |
|---|---|
| LipidBank | XPR1754 |
| LipidMaps | LMFA03010072 |
| CAS | |
| KEGG | {{{KEGG}}} |
| KNApSAcK | {{{KNApSAcK}}} |
| mol | LBF20207PG37 |
| Prostaglandin F_2α 1,15-lactone | |
|---|---|
| |
| Structural Information | |
| 9α,11α,15S-trihydroxy-prosta-5Z,13E-dien-1-oic acid, 1,15-lactone | |
| |
| Formula | C19H30O4 |
| Exact Mass | 322.21440944799997 |
| Average Mass | 322.4391 |
| SMILES | [C@@H]([C@@H]21)(CC=CCCC(=O)O[C@@H](CCCCC)C=C2)[C@@H](O)C[C@H]1O |
| Physicochemical Information | |
| Prostaglandin F2 alpha 1,15-lactone terminates pregnancy at early stage. Spilman_CH et al. | |
| Spectral Information | |
| Mass Spectra | |
| UV Spectra | |
| IR Spectra | |
| NMR Spectra | |
| Other Spectra | |
| Chromatograms | |
| Reported Metabolites, References | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
|
